ALX ONCOLOGY HOLDINGS INC Sublease Income
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Sublease Income of $2.50 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2025-11-07
- ALX ONCOLOGY HOLDINGS INC sublease income for the quarter ending 2025-09-30 was $0.00.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.50M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $2.50M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |